Immunic, Inc. (IMUX)
1.155
-0.04
(-3.75%)
USD |
NASDAQ |
Mar 18, 15:59
1.16
0.00 (0.00%)
After-Hours: 16:41
Immunic EPS Diluted (Quarterly) : -0.1603 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioRestorative Therapies, Inc. | -0.3333 |
| Quince Therapeutics, Inc. | -0.2492 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.30M |
| Total Expenses (Quarterly) | 19.30M |
| Enterprise Value | 141.65M |
| Earnings Yield | -64.63% |
| Normalized Earnings Yield | -64.63 |